UPC_APP_22399/2024

The Court of Appeal dismissed 10x Genomics' application for review (Wiederaufnahme) of an earlier appeal order concerning provisional measures in which 10x Genomics had lost to NanoString. The court held that re-examination of evidence assessment is not available via a review application, and that the court's use of the phrase 'in the court's technical assessment' did not constitute use of judges' personal opinions as evidence. The court also held there was a legal basis for the cost allocation decision in Rule 242.1 RoP.